In this report, we examine what lies ahead for healthcare AI in the new year. In November, a newly-assembled FDA advisory ...

BRL-201 is under clinical development by BRL Medicine and currently in Phase I for Diffuse Large B-Cell Lymphoma.

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

The agreement involves the advancement of the allogeneic CAR-T cell therapy platform into clinical trials ... antigen (BCMA)-targeting CAR-natural killer T (NKT) cells for Phase I trials of multiple ...

INR:7823. crash cart arrangement Northeast Pharmaceutical Dandong Pharmaceutical was punished by Liaoning Food and Drug Administration for illegally sellin ...

In a pivotal Phase 2 test of the Arcellx therapy ... a movement disorder. In Carvykti’s clinical trials, parkinsonism was reported in 3% (eight of 285) of study participants.

Cadrenal Therapeutics (CVKD) recapped its 2024 milestones and highlighted a clear path forward to develop the investigational drug tecarfarin ...

Amid recent backlash stemming from market withdrawals and trial delays, the FDA seeks to further clarify its requirements for ...

Expected readouts in diabetes, cancer and depression headline a series of study results that could help the biotechnology ...

We identified by searching the National Cancer Institute (NCI) Clinical Trials Support Unit database for all phase II/III trials conducted by NRG Oncology or its precursor NCI Cooperative Groups: ...

Lava Therapeutics has jettisoned its only wholly owned clinical-stage asset after the ... dubbed LAVA-1207, in a phase 1 trial for prostate-specific membrane antigen-positive metastatic castration ...